Prestige Consumer Healthcare PBH
NYSE PBH
$50.69 -0.99 (-1.92%)
At close: Aug 20, 2026 · 11:59 AM UTC

Prestige Consumer Healthcare (PBH) Return on Sales Growth (3y) (2013 - 2025)

Prestige Consumer Healthcare (PBH) Return on Sales Growth (3y) (2013 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS Growth (3y) (Qtr)
1 Haleon 44.05 Bn 43.08 Bn - -
2 Teva Pharmaceutical Industries 43.39 Bn 39.74 Bn 2.15 Bn 0.00
3 Zoetis 31.86 Bn 30.18 Bn 1.05 Bn 0.00
4 Takeda Pharmaceutical 28.78 Bn 22.99 Bn 5.10 Bn 0.00
5 United Therapeutics 22.25 Bn 19.59 Bn 683.80 Mn 0.00
6 Viatris 18.74 Bn 17.85 Bn 1.46 Bn 0.00
7 Neurocrine Biosciences 15.58 Bn 15.19 Bn 935.80 Mn 0.00
8 Elanco Animal Health 11.92 Bn 11.39 Bn 798.00 Mn 0.00
9 Dr Reddys Laboratories 10.16 Bn 9.99 Bn - -
10 Prestige Consumer Healthcare 2.43 Bn 2.36 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 0.00
Sep 30, 2024 0.00
Jun 30, 2024 0.00
Mar 31, 2024 0.00
Dec 31, 2023 0.00
Sep 30, 2023 0.00
Jun 30, 2023 0.00
Mar 31, 2023 -1.00
Dec 31, 2022 0.00
Sep 30, 2022 0.00
Jun 30, 2022 0.00
Mar 31, 2022 1.00
Dec 31, 2021 0.00
Sep 30, 2021 0.00
Jun 30, 2021 0.00
Mar 31, 2021 0.00